By simulating the life cycle of a minimal bacterial cell—from DNA replication to protein translation to metabolism and cell ...

The company’s magnetic bead platform aims to remove one of cancer diagnostics’ biggest bottlenecks by simplifying the capture of cell-free DNA from blood samples.

University of Edinburgh spin-out BIOCAPTIVA secures £1.58m funding and launches its msX liquid biopsy technology in the US to improve cancer diagnostics and research.

Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...

With clinical data beginning to emerge, big pharma is signaling its belief that in vivo CAR generation is the next immunotherapy breakthrough.

Driving R&D Translation and Sector Collaboration; Elevating Hong Kong as a Global Life & Health Innovation HubHONG KONG SAR - Media OutReach Newswire - 9 March 2026 - The ...

Nick Pearson, CIO at Ricoh Europe, describes his job as energising. The company’s shift in business model presents challenges and significant opportunities for him to draw on previous experience at ...

“The market potential for the technology is remarkable” – Sarah Hardy, director, Archangels ...

Apple’s $599 MacBook Neo is generating hype, but it won’t kill Windows laptops. Here’s why budget Windows PCs will remain ...

KOMODO-1 first-in-human clinical trial of BBI-940 open for enrollment $108 million in cash provides runway into the second half of 2028, through expected clinical proof-of-concept readout for KOMODO-1 ...

Fast Track designation aims to facilitate development and expedite review of drugs, such as PBGENE-DMD to treat serious conditions like Duchenne muscular dystrophy – – March 17, 2026 virtual webinar ...

Automatic tool changer systems are now an important part of many robot and automated solutions, proving key to maintaining flexibility to meet consumer demands. Automated tool changer systems enable ...